The safety of 52 weeks of oral DHEA therapy for postmenopausal women.

Authors: Panjari M, Bell RJ, Jane F, Adams J, Morrow C, Davis SR.

Publication Year: 2009

Citation: Maturitas. 2009; 63(3):240-5.

In this study, 93 postmenopausal women received either 50 mg/day DHEA or placebo for 52 weeks.  No significant changes, either beneficial or adverse, were seen in the lipid profile (HDL, LDL, total cholesterol and triglycerides), the endometrium, or development of insulin resistance (fasting glucose, fasting insulin, or HOMA-IR).